If you need help accessing our website, call 855-698-9991
NYU Langone Provider

Charles R. Marmar, MD

NYU Langone Provider
  • Specialty: Psychiatry
  • Treats: Adults
  • Language: English
  • Phone: 212-263-7419
View Locations

My father was a general surgeon, and I was always very interested in his work. While participating in an elective in cardiothoracic surgery as a medical student, I interacted with many people who were facing life-threatening illnesses. This stimulated my interest in psychiatry, and specifically in traumatic stress.

Charles Marmar, MD
Charles Marmar Biosketch Video
Video Player is loading.
0:00
/
0:00
Loaded: 0%
0:00
Progress: 0%
Stream TypeLIVE
0:00
 
1x

My research has led to breakthroughs in our understanding of post-traumatic stress disorder (PTSD) through the study of police officers, soldiers in combat, veterans, and civilians who have been exposed to sudden, usually life-threatening events. By mapping out circuits of the brain, researchers in our Department of Psychiatry are also making advances in how we diagnose, treat, and prevent conditions like schizophrenia, addiction, depression, dementia, and traumatic brain injury.

At NYU Langone, we not only have expertise in treating mental health conditions, but our clinicians also have compassion and a commitment to patients that go far beyond simply providing quality care. I take the time to listen to what my patients are feeling. From so many years of supporting people dealing with mental illness, I understand and empathize with the pain they’re going through. I am deeply committed to developing a trusting relationship to help patients recover their sense of effectiveness and hope for the future.

Positions
Board Certifications
  • American Board of Psychiatry & Neurology - Psychiatry, 1982
Education and Training
  • Fellowship, Langley Porter Psychiatric Inst., Psychiatry, 1978
  • Residency, University of California - San Francisco, Psychiatry, 1978
  • Residency, University of Toronto, Psychiatry, 1976
  • MD from University Of Manitoba, 1970

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
     
    • AETNA EPO (NYULH Employees)
    • AETNA EPO (Sunset Park Employees)
    • Aetna EPO (AMEX employees)
    • Aetna POS (American Express Employer)
  • United Healthcare
     
    • United Healthcare (NY University Care Plan)
    • United Healthcare Choice (AMEX employees)
    • United Healthcare Choice (Blackrock employees)
    • United Healthcare Choice (CBS employees)
    • United Healthcare Choice (Simon
    • United Healthcare EPO (NYU Langone Health Employees)
    • United Healthcare EPO (Sunset Park Employees)
    • United Healthcare Indemnity (NYU Langone Health Employees)
    • United Healthcare NYU Care (NYULH Employees)
    • United Healthcare NYU Care (Sunset Park Employees)
    • United Healthcare Nexus (Amex Employees)
    • United Healthcare Plus (NYU Langone Health Employees)
    • United Healthcare Plus (Sunset Park Employees)
    • United Healthcare Student Resources (NYU)
    • United Healthcare Value, Advantage and HDHP (New York University employees)
This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

NYU Langone Psychiatry Associates

1 Park Avenue, 8th Floor, New York, NY 10016

“The discovery of biomarkers for psychiatric conditions is advancing how we diagnose and treat these disorders.”

Charles R. Marmar, MD Psychiatrist

Interests

imaging

Research Summary

I am Peter H. Schub Professor and Chair of the Department of Psychiatry at NYU Grossman School of Medicine, and I am the Director of the NYU Langone Health Center for Precision Medicine in Alcohol Use Disorder and PTSD. My primary research focus revolves around the utilization of genomic and circuit biomarkers to forward the field of precision medicine specifically addressing alcohol use disorder and PTSD. Currently, I am the Principal Investigator on several projects supported by NIH and the Department of Defense. These include an NIH P01 center grant focused on harnessing biomarkers to customize treatments for alcohol use disorder comorbid with PTSD; a Department of Defense Center grant dedicated to enriching our understanding of clinical subtypes and their endophenotypes for military service–related PTSD and thus refining precision psychiatry; and an NIH R01 for enhancing precision medicine for Gabapentin treatment of AUD through system pharmacology. Furthermore, I am Co-Principal Investigator for a DARPA project whose focus is to not only build resilience in healthcare workers, but to do so by harnessing wellness platforms and advanced computational modeling. My recent research achievements include the discovery of genomic, metabolomic, and proteomic biomarkers for PTSD diagnostic screening for veterans, the use of speech-based biomarkers for diagnostic screening of PTSD in veterans, identifying pre-deployment genomic, metabolomic, and proteomic biomarkers to predict PTSD in active military personnel, and employing advanced computational machine learning methods for building causal models of clinical features. This last advancement aids in identifying likely responders to the Extended-Release Gabapentin Enacarbil treatment for alcohol use disorder.

Academic Contact

Academic office

One Park Avenue

Eighth Floor

New York, NY 10016

Phone

646-754-4855

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Skip timelineStress Disorders, Post-TraumaticVeteransPoliceCombat DisordersStress, Psychological
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

    Learn More
  • Cannabidiol for Treating PTSD symptoms and Neurocognitive Impairment in PTSD and PTSD Comorbid with TBI: A Placebo-controlled RCT with Neural-circuit centered Precision Medicine Prediction of Response.

    Learn More
View All Research Studies (2)

Related News